Expression of serum inflammatory markers in colorectal cancer and their relationship with clinical pathological characteristics
American Journal of Translational Research · 2026 · 18 (5) · 3961-3971
DOI: 10.62347/jcse4333 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Xiangxia Jian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Affiliated Hospital of Zunyi Medical University Zunyi 563000, Guizhou, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: This retrospective study primarily aimed to measure serum inflammatory markers in colorectal cancer and examine their relationship with clinical pathological characteristics. METHODS: A total of 147 CRC patients (assigned to the training group (103 cases) or the validation group (44 cases) at a 7:3 ratio) and 100 control participants were enrolled. Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) levels in serum were compared between the training and control groups. The diagnostic value of these markers for CRC and their relationship with the clinical pathological characteristics of CRC patients were evaluated. The correlations among inflammatory markers and their correlations with tumor markers were analyzed. Finally, the clinical data of the training and validation groups were compared, and the diagnostic value of each inflammatory marker was verified in the validation group. RESULTS: Inflammatory markers were notably elevated in the CRC group and showed significant correlations with Tumor-Node-Metastasis (TNM) staging, lymph node metastasis (LNM), and tumor diameter. Additionally, all these three markers showed positive correlations with each other and with tumor markers. Each inflammatory marker demonstrated certain diagnostic efficacy for clinical pathological characteristics. Specifically, IL-6 exhibited outstanding efficacy for LNM (area under the curve (AUC) = 0.798), and CRP performed best in differentiating tumor diameter (AUC = 0.730). Moreover, the AUC values in the validation group were comparable to those in the training group. RESULTS: IL-6, TNF-α, and CRP may serve as potential tools to assist in the assessment of disease progression and metastatic potential in colorectal cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Affiliated Hospital of Zunyi Medical University Zunyi 563000, Guizhou, China.
Zitieren
APA
Jian, X., & Wen, K. (2026). Expression of serum inflammatory markers in colorectal cancer and their relationship with clinical pathological characteristics. American Journal of Translational Research, 18(5), 3961-3971. https://doi.org/10.62347/jcse4333
Vancouver
Jian X, Wen K. Expression of serum inflammatory markers in colorectal cancer and their relationship with clinical pathological characteristics. American Journal of Translational Research. 2026;18(5):3961-3971. doi:10.62347/jcse4333
BibTeX
@article{Jian2026,
author = {Jian, Xiangxia and Wen, Kunming},
title = {Expression of serum inflammatory markers in colorectal cancer and their relationship with clinical pathological characteristics},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {5},
pages = {3961--3971},
doi = {10.62347/jcse4333}
}
EUVIMED